PIRAMAL PHARMA
|
The Current P/S Ratio of PIRAMAL PHARMA is 3.58.
Share Price | ₹234.9 | Jan 14,2025 |
Market Cap | ₹31,134.1 Cr | |
Sales-TTM | ₹8,703.8 Cr | TTM-Consolidated Results |
Price/Sales | 3.58x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of PIRAMAL PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹31,134.1 Cr] as on Jan 14,2025
(/) Sales [ ₹8,703.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.58x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay '3.58 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PIRAMAL PHARMA !
The chart below summarizes the trend in P/S Ratio of PIRAMAL PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of PIRAMAL PHARMA
PS Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2021 averaged 0.81x.
- PIRAMAL PHARMA 's operated at median p/e ratio of 1.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2024 at 2.09x.
- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does PIRAMAL PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
PIRAMAL PHARMA | 8,703.8 | 3.58 | 31,134.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.44 | 424,382.0 |
CIPLA LTD | 26,512.0 | 4.41 | 116,854.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.71 | 111,746.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.69 | 100,704.0 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.11 | 156,037.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.72 | 107,078.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.81 | 110,142.0 |
LUPIN LTD | 21,431.3 | 4.53 | 97,093.5 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.20 | 66,638.3 |
ABBOTT INDIA LTD | 6,066.1 | 9.73 | 58,996.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PIRAMAL PHARMA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.20x |
Max industry PS | 18.11x |
Median industry PS | 4.69x |
Average industry PS | 7.18x |
You may also like the below Video Courses